Friday, July 10, 2026

pharma · Ependymoma, Medulloblastoma · chronically occluded coronary artery

Ishita Pharma -

Ishita Pharma - clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Mumbai, IN HQ
3 Employees
EMA registrant Type
Company details
Status
Public
HQ
Mumbai, IN
Employees
3
Programs
8
Drugs
19
Patents
0
Intelligence · Clinical Programs

Ishita Pharma - projects

0 ClinicalTrials.gov programs sponsored by Ishita Pharma -.

Ishita Pharma - has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Ishita Pharma - have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.